SEC Filings

Filing date	Form	Description	View
09/03/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009566.pdf 0001179110-20-009566.rtf 0001179110-20-009566.xls
09/01/20	S-3ASR	S-3ASR	View HTML 0001104659-20-101456.pdf 0001104659-20-101456.rtf 0001104659-20-101456.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009259.pdf 0001179110-20-009259.rtf 0001179110-20-009259.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009261.pdf 0001179110-20-009261.rtf 0001179110-20-009261.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009263.pdf 0001179110-20-009263.rtf 0001179110-20-009263.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009265.pdf 0001179110-20-009265.rtf 0001179110-20-009265.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009267.pdf 0001179110-20-009267.rtf 0001179110-20-009267.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009269.pdf 0001179110-20-009269.rtf 0001179110-20-009269.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009271.pdf 0001179110-20-009271.rtf 0001179110-20-009271.xls
08/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-009273.pdf 0001179110-20-009273.rtf 0001179110-20-009273.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.